Recognized by industry leaders for extensive coverage on African Asset Management
SPE Capital and Proparco in Moroccan pharma deal
This product is currently unavailable.
Description
456
SPE Capital Partners has acquired Saham Pharma, an antibiotics manufacturer and major hospital provider in Morocco, alongside Proparco as a minority investor.
